Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Eden Research fungicide added to German organics list
(Sharecast News) - Sustainable biopesticides and biocontrol specialist Eden Research announced on Wednesday that its flagship fungicide Mevalone has been added to the Organic Input List by FiBL Germany - a key certification for products used in organic farming. The AIM-traded firm said the inclusion followed the approval of Mevalone in Germany earlier in the year.
It said the Organic Input List is managed by the Research Institute of Organic Agriculture (FiBL), an organisation focussed on sustainability and organic farming standards.
The certification confirmed that Mevalone met stringent requirements for use in organic production across Germany and several other countries.
Eden said the registration aligned with Germany's 2030 organic strategy, which aimed to increase organic farmland to 30% by the end of the decade - exceeding the EU Green Deal target of 25%.
Mevalone could play a pivotal role in helping German farmers meet those goals while maintaining productivity, the company explained, by providing effective control of fungal diseases in compliance with organic standards.
"Mevalone's inclusion in the Organic Input List by FiBL Germany provides us with another vital organic registration in an important market, following in the footsteps of Greece, Italy, and France," said chief executive officer Sean Smith.
"Our products' organic compliance demonstrates their sustainable qualities based on Eden's terpene chemistry, as well as their strong efficacy, even when compared with conventional pesticides."
Smith said Germany currently had about 10% of its apple orchards and 15% of vineyard areas dedicated to organic farming, adding that indications were that the proportions of organic farmland were growing rapidly.
"Against this backdrop, we have strategically positioned Mevalone as one of the leading alternative fungicide products that fits both the conventional and organic farming needs."
At 1100 GMT, shares in Eden Research were up 3.9% at 4p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
